Document is current
Any future updates will be listed below
-
Authors
- License Information
-
More Information
Article History
Received: 14 November 2024
Accepted: 28 January 2025
First Online: 10 March 2025
Declarations
:
: The authors have no conflicts of interest to declare related to the manuscript. Unrelated to this work: DK declares honoraria from MSD (speaker/moderator in sponsored symposia) and from NAPP Pharmaceutical Limited (speaker); CR declares speaker fees from MSD, Pfizer, Shionogi, AOP Orphan, bioMérieux and Advanz Pharma. CR received fees as Advisory Board member from Advanz Pharma, bioMérieux and Viatris.
Free to read: This content has been made available to all.
